5Schanden LD, Connoly AB, Hill GL, et al. Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis[J]. Ann Surg, 1998, 228(2):146-158.
6Bresson JL, Jeay S, Gagnerault MC, et al. Growth hormone and prolactin receptors in human peripheral blood mononuclear cell:relation with age and GH-binding protein[J]. Endocrinology,1999,140(7):3203-3209.
3Dorshkind K, Horseman ND. The roles of prolactin, growth hormone, insulin like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency [ J ]. Endocr Rev, 2000,21
4Haeffner A, Thieblemont N, Deas O, et al. Inhibitory effect of growth hormone on TNF-alpha secretion and nuclear factor-kappaB translocation in lipopolysaccharide stimulated human monocytes [ J ]. Immunology, 1997, 158(3): 1310-1314.
5Guzman ML, Neering SJ, Upchurch D, et al. Nuclear factor-kappaB is constitutively activatedin primitive human acute myelogenous leukemia cells [J]. Blood,2001,98(8) :2301-2307.
6Schanden LD, Connoly AB, Hill GL, et al. Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis[J]. Ann Surg, 1998,228(2): 146-158.
7Mello-Coelho V, Gagnerault MC, Souberbielle JC, et al. Growth hormone and its receptor are expressed in human thymic cells[J]. Endocrinology, 1998,139(9): 3837-3842.
8Dobashi H, Sato M, Tanaka T, et al. Growth hormone restores glucocorticoidinduced T cell suppression[J]. FASEB J,2001,15(10): 1861-1863.
9Jeay S, Sonenshein GE, Postel-Vinay MC, et al. Growth hormone prevents apoptosis through activation of nuclear factor-kappaB in interleukin-3-dependent Ba/F3 cell line[J]. Mol Endocrinol,2000,14(5) :650-661.
10Ghosh S, May MJ, Kopp EB. NF-kappaB and Rel proteins: evolutionarily conserved mediators of immune responses[J]. Annu Rev Immunol, 1998,16:225 -260.
2A P South,G H S Ashton,et al.EEC(Ectrodactyly,Ectodermal dysplasia,Clefting) syndrome:heterozygous mutation in the p63 gene (R279H) and DNA-based prenatal diagnosis[J].British Journal of Dermatology 2002,146:216-220.
3Sprecher E,Molho-Pessach V,Ingber A,et al.Homozygous splice site mutations in PKP1 result in loss of epidermal plakophilin 1 expression and underlie ectodermal dysplasia/skin fragility syndrome in two consanguineous families[J].J Invest Dermatol,2004,122(3):647-51.
4Hashiguchi T,Yotsumoto S,Kanzki T et al.Mutations in the ED1 gene in Japannese families with X-linked hypohidrotic ectodermal dysplasia[J].Exp Dermatol 2003,12:518-522.
5Atila F V,Ricardo L R.de Souza et al.X-linked hypohidrotic ectodermal dysplasia mutations in Brazilian families[J].American Journal of Medical Geneties,2003,122A:51-55.
6Xue-Jun Zhang,Jian-Jun Chen,et al.Mutation analysis of the ED1 gene in two Chinese Han families with X-linked hypohidrotic ectodermal dysplasia[J].Arch Dermatol Res,2003,295:38-42.
7Akiko Nishibu,Takaki Hashiguchi,et al.A Frameshift mutation of ED1 gene in Sibling cases with X-linked hypohidrotic ectodermal dysplasia[J].Dermatology 2003:207:178-181.
